News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pharm-Olam International Ltd. Expands Operations with New Appointment, Connie Andrews



2/8/2011 8:59:43 AM

HOUSTON, TEXAS February 8, 2011. Pharm-Olam International Ltd. (POI) a multi-national full service CRO to the pharmaceutical and biotech industries announces the appointment of Connie Andrews as Vice President of Global Services.

Ms. Andrews brings more than 28 years of clinical research experience across multiple therapeutic areas. Prior to joining POI, Andrews served as the Global Biotech Unit Head at a major global CRO where she redesigned workflow processes to meet the needs of small to medium sized companies who work within tighter constraints and timelines.

She has held senior operations positions for large and medium sized pharmaceutical and biotech companies and led many global initiatives and process improvement plans to implement operating efficiencies and strategic programs resulting in increased effectiveness and winning study designs.

“Connie has a long history of success coordinating multiple departments”, said John Hovre, COO. “Together with our experienced, senior management she will provide guidance to sponsors to complete challenging objectives for their multinational trials.”

For further information about conducting trials with Pharm-Olam please contact John Hovre, COO at john.hovre@pharm-olam.com.

About Pharm-Olam International Group

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, POI focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES